deltatrials
Completed PHASE4 INTERVENTIONAL 1-arm NCT00986102

PROUD Study: A Prospective Study on the Usage Patterns of Doripenem in the Asia Pacific Region

A Prospective Study on the Usage Patterns of Doripenem in the Asia Pacific Region

Sponsor: Janssen Research & Development, LLC

Interventions doripenem
Updated 7 times since 2017 Last updated: Oct 24, 2024 Started: Jul 17, 2009 Primary completion: Sep 5, 2011 Completion: Sep 9, 2011
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00986102, this PHASE4 trial focuses on Pneumonia and Pneumonia, Ventilator-Associated and remains completed. Sponsored by Janssen Research & Development, LLC, it has been updated 7 times since 2009, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Dec 2024 · 3 months · monthly snapshotCompleted~Dec 2024 – ~Sep 2025 · 9 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

7 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed PHASE4

  2. Dec 2024 — Sep 2025 [monthly]

    Completed PHASE4

  3. Sep 2024 — Dec 2024 [monthly]

    Completed PHASE4

  4. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  5. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

Show 2 earlier versions
  1. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  2. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE4

    First recorded

Jul 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Janssen Research & Development, LLC
  • Johnson & Johnson (Hong Kong) Ltd.
Data source: Janssen Research & Development, LLC

For direct contact, visit the study record on ClinicalTrials.gov .